Edinburgh Research and Innovation is seeking partners to commercialise the next generation of malaria drugs and vaccine.

Edinburgh University has announced that it has identified a key protein that could prove the turning point in the fight against malaria.

The University’s commercialisation unit, Edinburgh Research and Innovation, is now actively seeking investment partners in order to commercialise the research into an effective drug or vaccine.

Researchers at Edinburgh’s School of Biological Sciences found a protein which binds red blood cells and causes lethal clotting ‘rosettes’ common to different strains of the malaria parasite. Initial research found that…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?